The goiter of Hashimoto's thyroiditis may remain unchanged for decades(37), but usually it gradually increases in size
The anti-aging skin claims are supported by in vitro, animal, and observational human data, which is consistent with what providers and patients report clinically
None of the three GLOW compounds are FDA-approved for injectable human use as of June 2026
This explains why patients experience symptoms that come and go unpredictably
Thalidomide is associated with edema, sinus bradycardia, venous thromboembolism, and lenalidomide is associated with hypersensitivity myocarditis, and high-dose interleukin-2 is associated with fulminant myocarditis
Prescribers should request Certificates of Analysis (COA) from the compounding pharmacy, confirm the actual copper content per vial, and use a single pharmacy source throughout treatment to minimize batch-to-batch variation